Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001503 · ClinicalTrials.gov registry record
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1,031
- Enrollment target
NCT00001503: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001503 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,031 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001503 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1,031 participants
- Enrollment target
Study Summary
This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,031 participants |
| Start Date | 1996-09-19 |
| Est. Completion | 2023-06-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001503
The ClinicalTrials.gov registry entry for NCT00001503 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,031 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001503 about?
NCT00001503 is a clinical study titled "Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease". This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.
What is the current status of trial NCT00001503?
This trial is currently completed. The enrollment target is 1,031 participants. The study started on 1996-09-19. Estimated completion is 2023-06-15.
Who is sponsoring clinical trial NCT00001503?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.